Al Hammadi's Sudair Pharmaceutical Co. Files IPO Application for Saudi Bourse Listing

MT Newswires · 2d ago
01:33 AM EST, 12/07/2025 (MT Newswires) -- Al Hammadi Holding (SASE:4007) said Sunday that its affiliate Sudair Pharmaceutical Co. filed for an initial public offering with the Saudi Arabian Capital Market Authority. The Saudi Arabia-listed integrated healthcare group noted that its 35%-owned Sudair Pharmaceutical is seeking to list its shares on the Saudi Exchange's main market.